[1]
Greco, F., Piacentini, P., Remo, A., Bonetti, A. and Ferrandina, G. 2016. Case 2 – Trabectedin as a maintenance therapy in a patient with recurrent ovarian cancer and BRCA1 germline mutation:  . Cancer Breaking News. 4, 1 (Mar. 2016), 41–44. DOI:https://doi.org/10.19156/cbn.2016.0008.